RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19 | -26.9% | 14,854 | -27.3% | 0.00% | – |
| Q1 2023 | $26 | -90.4% | 20,429 | -88.7% | 0.00% | -100.0% |
| Q4 2022 | $272 | -100.0% | 181,355 | -83.3% | 0.00% | -71.4% |
| Q3 2022 | $1,278,000 | +208.7% | 1,083,635 | +681.4% | 0.01% | +366.7% |
| Q1 2022 | $414,000 | +4.8% | 138,674 | -7.2% | 0.00% | +50.0% |
| Q4 2021 | $395,000 | -39.8% | 149,377 | -17.4% | 0.00% | -50.0% |
| Q3 2021 | $656,000 | +1071.4% | 180,819 | +1279.7% | 0.00% | +300.0% |
| Q2 2021 | $56,000 | -40.4% | 13,106 | -52.7% | 0.00% | 0.0% |
| Q1 2021 | $94,000 | -52.3% | 27,696 | -51.0% | 0.00% | -75.0% |
| Q4 2020 | $197,000 | +756.5% | 56,486 | +411.5% | 0.00% | +300.0% |
| Q4 2019 | $23,000 | -17.9% | 11,043 | -9.5% | 0.00% | -75.0% |
| Q4 2018 | $28,000 | – | 12,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |